128 related articles for article (PubMed ID: 7577895)
21. Cervical mucus peroxidase is a reliable indicator for ovulation in humans.
Anderson WA; Ahluwalia BS; Westney LS; Burnett CC; Rüchel R
Fertil Steril; 1984 May; 41(5):697-702. PubMed ID: 6325254
[TBL] [Abstract][Full Text] [Related]
22. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
Mendelson JH; Mello NK; Teoh SK; Ellingboe J
J Pharmacol Exp Ther; 1989 Sep; 250(3):902-9. PubMed ID: 2506337
[TBL] [Abstract][Full Text] [Related]
23. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
24. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
26. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.
Merz-Demlow BE; Duncan AM; Wangen KE; Xu X; Carr TP; Phipps WR; Kurzer MS
Am J Clin Nutr; 2000 Jun; 71(6):1462-9. PubMed ID: 10837286
[TBL] [Abstract][Full Text] [Related]
27. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
28. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone.
Beitins IZ; McArthur JW; Turnbull BA; Skrinar GS; Bullen BA
J Clin Endocrinol Metab; 1991 Jun; 72(6):1350-8. PubMed ID: 1902847
[TBL] [Abstract][Full Text] [Related]
29. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
30. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
31. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
Sherman BM; West JH; Korenman SG
J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
33. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
34. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones.
Leyendecker G; Wardlaw S; Nocke W
Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011
[TBL] [Abstract][Full Text] [Related]
35. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
36. Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity.
Guidoux S; Garnier PE; Schimpff RM
Horm Res; 1986; 23(1):31-7. PubMed ID: 3079724
[TBL] [Abstract][Full Text] [Related]
37. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of ovulation induction.
Wu CH
Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
[TBL] [Abstract][Full Text] [Related]
39. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM; Lenton EA; Roberts I; Cooke ID
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[TBL] [Abstract][Full Text] [Related]
40. [Blood serum content of prolactin, follicle-stimulating hormone, luteinizing hormone, estradiol and progesterone in women with normal menstrual cycle].
Khamad'ianov UR; Laricheva IP; Smirnova LK
Probl Endokrinol (Mosk); 1980; 26(2):32-7. PubMed ID: 6769108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
